This report aims to provide a comprehensive presentation of the global market for Standalone Cancer Registry Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Standalone Cancer Registry Software. This report contains market size and forecasts of Standalone Cancer Registry Software in global, including the following market information:
Global Standalone Cancer Registry Software Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Standalone Cancer Registry Software market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Public Database Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Standalone Cancer Registry Software include McKesson Corporation, Elekta, C/NET Solutions, Electronic Registry Systems, Rocky Mountain Cancer Data Systems and Onco, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Standalone Cancer Registry Software companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Standalone Cancer Registry Software Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Standalone Cancer Registry Software Market Segment Percentages, by Type, 2022 (%)
Public Database
Commercial Database
Global Standalone Cancer Registry Software Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Standalone Cancer Registry Software Market Segment Percentages, by Application, 2022 (%)
Hospitals
Healthcare Providers
Research Centers
Others
Global Standalone Cancer Registry Software Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Standalone Cancer Registry Software Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Standalone Cancer Registry Software revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Standalone Cancer Registry Software revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
McKesson Corporation
Elekta
C/NET Solutions
Electronic Registry Systems
Rocky Mountain Cancer Data Systems
Onco
Outline of Major Chapters:
Chapter 1: Introduces the definition of Standalone Cancer Registry Software, market overview.
Chapter 2: Global Standalone Cancer Registry Software market size in revenue.
Chapter 3: Detailed analysis of Standalone Cancer Registry Software company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Standalone Cancer Registry Software in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Standalone Cancer Registry Software Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Standalone Cancer Registry Software Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Standalone Cancer Registry Software Overall Market Size
2.1 Global Standalone Cancer Registry Software Market Size: 2022 VS 2029
2.2 Global Standalone Cancer Registry Software Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Standalone Cancer Registry Software Players in Global Market
3.2 Top Global Standalone Cancer Registry Software Companies Ranked by Revenue
3.3 Global Standalone Cancer Registry Software Revenue by Companies
3.4 Top 3 and Top 5 Standalone Cancer Registry Software Companies in Global Market, by Revenue in 2022
3.5 Global Companies Standalone Cancer Registry Software Product Type
3.6 Tier 1, Tier 2 and Tier 3 Standalone Cancer Registry Software Players in Global Market
3.6.1 List of Global Tier 1 Standalone Cancer Registry Software Companies
3.6.2 List of Global Tier 2 and Tier 3 Standalone Cancer Registry Software Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Standalone Cancer Registry Software Market Size Markets, 2022 & 2029
4.1.2 Public Database
4.1.3 Commercial Database
4.2 By Type - Global Standalone Cancer Registry Software Revenue & Forecasts
4.2.1 By Type - Global Standalone Cancer Registry Software Revenue, 2018-2023
4.2.2 By Type - Global Standalone Cancer Registry Software Revenue, 2024-2029
4.2.3 By Type - Global Standalone Cancer Registry Software Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Standalone Cancer Registry Software Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Healthcare Providers
5.1.4 Research Centers
5.1.5 Others
5.2 By Application - Global Standalone Cancer Registry Software Revenue & Forecasts
5.2.1 By Application - Global Standalone Cancer Registry Software Revenue, 2018-2023
5.2.2 By Application - Global Standalone Cancer Registry Software Revenue, 2024-2029
5.2.3 By Application - Global Standalone Cancer Registry Software Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Standalone Cancer Registry Software Market Size, 2022 & 2029
6.2 By Region - Global Standalone Cancer Registry Software Revenue & Forecasts
6.2.1 By Region - Global Standalone Cancer Registry Software Revenue, 2018-2023
6.2.2 By Region - Global Standalone Cancer Registry Software Revenue, 2024-2029
6.2.3 By Region - Global Standalone Cancer Registry Software Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Standalone Cancer Registry Software Revenue, 2018-2029
6.3.2 US Standalone Cancer Registry Software Market Size, 2018-2029
6.3.3 Canada Standalone Cancer Registry Software Market Size, 2018-2029
6.3.4 Mexico Standalone Cancer Registry Software Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Standalone Cancer Registry Software Revenue, 2018-2029
6.4.2 Germany Standalone Cancer Registry Software Market Size, 2018-2029
6.4.3 France Standalone Cancer Registry Software Market Size, 2018-2029
6.4.4 U.K. Standalone Cancer Registry Software Market Size, 2018-2029
6.4.5 Italy Standalone Cancer Registry Software Market Size, 2018-2029
6.4.6 Russia Standalone Cancer Registry Software Market Size, 2018-2029
6.4.7 Nordic Countries Standalone Cancer Registry Software Market Size, 2018-2029
6.4.8 Benelux Standalone Cancer Registry Software Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Standalone Cancer Registry Software Revenue, 2018-2029
6.5.2 China Standalone Cancer Registry Software Market Size, 2018-2029
6.5.3 Japan Standalone Cancer Registry Software Market Size, 2018-2029
6.5.4 South Korea Standalone Cancer Registry Software Market Size, 2018-2029
6.5.5 Southeast Asia Standalone Cancer Registry Software Market Size, 2018-2029
6.5.6 India Standalone Cancer Registry Software Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Standalone Cancer Registry Software Revenue, 2018-2029
6.6.2 Brazil Standalone Cancer Registry Software Market Size, 2018-2029
6.6.3 Argentina Standalone Cancer Registry Software Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Standalone Cancer Registry Software Revenue, 2018-2029
6.7.2 Turkey Standalone Cancer Registry Software Market Size, 2018-2029
6.7.3 Israel Standalone Cancer Registry Software Market Size, 2018-2029
6.7.4 Saudi Arabia Standalone Cancer Registry Software Market Size, 2018-2029
6.7.5 UAE Standalone Cancer Registry Software Market Size, 2018-2029
7 Standalone Cancer Registry Software Companies Profiles
7.1 McKesson Corporation
7.1.1 McKesson Corporation Company Summary
7.1.2 McKesson Corporation Business Overview
7.1.3 McKesson Corporation Standalone Cancer Registry Software Major Product Offerings
7.1.4 McKesson Corporation Standalone Cancer Registry Software Revenue in Global Market (2018-2023)
7.1.5 McKesson Corporation Key News & Latest Developments
7.2 Elekta
7.2.1 Elekta Company Summary
7.2.2 Elekta Business Overview
7.2.3 Elekta Standalone Cancer Registry Software Major Product Offerings
7.2.4 Elekta Standalone Cancer Registry Software Revenue in Global Market (2018-2023)
7.2.5 Elekta Key News & Latest Developments
7.3 C/NET Solutions
7.3.1 C/NET Solutions Company Summary
7.3.2 C/NET Solutions Business Overview
7.3.3 C/NET Solutions Standalone Cancer Registry Software Major Product Offerings
7.3.4 C/NET Solutions Standalone Cancer Registry Software Revenue in Global Market (2018-2023)
7.3.5 C/NET Solutions Key News & Latest Developments
7.4 Electronic Registry Systems
7.4.1 Electronic Registry Systems Company Summary
7.4.2 Electronic Registry Systems Business Overview
7.4.3 Electronic Registry Systems Standalone Cancer Registry Software Major Product Offerings
7.4.4 Electronic Registry Systems Standalone Cancer Registry Software Revenue in Global Market (2018-2023)
7.4.5 Electronic Registry Systems Key News & Latest Developments
7.5 Rocky Mountain Cancer Data Systems
7.5.1 Rocky Mountain Cancer Data Systems Company Summary
7.5.2 Rocky Mountain Cancer Data Systems Business Overview
7.5.3 Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Major Product Offerings
7.5.4 Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Revenue in Global Market (2018-2023)
7.5.5 Rocky Mountain Cancer Data Systems Key News & Latest Developments
7.6 Onco
7.6.1 Onco Company Summary
7.6.2 Onco Business Overview
7.6.3 Onco Standalone Cancer Registry Software Major Product Offerings
7.6.4 Onco Standalone Cancer Registry Software Revenue in Global Market (2018-2023)
7.6.5 Onco Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Standalone Cancer Registry Software Market Opportunities & Trends in Global Market
Table 2. Standalone Cancer Registry Software Market Drivers in Global Market
Table 3. Standalone Cancer Registry Software Market Restraints in Global Market
Table 4. Key Players of Standalone Cancer Registry Software in Global Market
Table 5. Top Standalone Cancer Registry Software Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Standalone Cancer Registry Software Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Standalone Cancer Registry Software Revenue Share by Companies, 2018-2023
Table 8. Global Companies Standalone Cancer Registry Software Product Type
Table 9. List of Global Tier 1 Standalone Cancer Registry Software Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Standalone Cancer Registry Software Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Standalone Cancer Registry Software Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Standalone Cancer Registry Software Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Standalone Cancer Registry Software Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Standalone Cancer Registry Software Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Standalone Cancer Registry Software Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Standalone Cancer Registry Software Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Standalone Cancer Registry Software Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Standalone Cancer Registry Software Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Standalone Cancer Registry Software Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Standalone Cancer Registry Software Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Standalone Cancer Registry Software Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Standalone Cancer Registry Software Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Standalone Cancer Registry Software Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Standalone Cancer Registry Software Revenue, (US$, Mn), 2024-2029
Table 30. McKesson Corporation Company Summary
Table 31. McKesson Corporation Standalone Cancer Registry Software Product Offerings
Table 32. McKesson Corporation Standalone Cancer Registry Software Revenue (US$, Mn) & (2018-2023)
Table 33. McKesson Corporation Key News & Latest Developments
Table 34. Elekta Company Summary
Table 35. Elekta Standalone Cancer Registry Software Product Offerings
Table 36. Elekta Standalone Cancer Registry Software Revenue (US$, Mn) & (2018-2023)
Table 37. Elekta Key News & Latest Developments
Table 38. C/NET Solutions Company Summary
Table 39. C/NET Solutions Standalone Cancer Registry Software Product Offerings
Table 40. C/NET Solutions Standalone Cancer Registry Software Revenue (US$, Mn) & (2018-2023)
Table 41. C/NET Solutions Key News & Latest Developments
Table 42. Electronic Registry Systems Company Summary
Table 43. Electronic Registry Systems Standalone Cancer Registry Software Product Offerings
Table 44. Electronic Registry Systems Standalone Cancer Registry Software Revenue (US$, Mn) & (2018-2023)
Table 45. Electronic Registry Systems Key News & Latest Developments
Table 46. Rocky Mountain Cancer Data Systems Company Summary
Table 47. Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Product Offerings
Table 48. Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Revenue (US$, Mn) & (2018-2023)
Table 49. Rocky Mountain Cancer Data Systems Key News & Latest Developments
Table 50. Onco Company Summary
Table 51. Onco Standalone Cancer Registry Software Product Offerings
Table 52. Onco Standalone Cancer Registry Software Revenue (US$, Mn) & (2018-2023)
Table 53. Onco Key News & Latest Developments
List of Figures
Figure 1. Standalone Cancer Registry Software Segment by Type in 2022
Figure 2. Standalone Cancer Registry Software Segment by Application in 2022
Figure 3. Global Standalone Cancer Registry Software Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Standalone Cancer Registry Software Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Standalone Cancer Registry Software Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Standalone Cancer Registry Software Revenue in 2022
Figure 8. By Type - Global Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 9. By Application - Global Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 10. By Type - Global Standalone Cancer Registry Software Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 12. By Application - Global Standalone Cancer Registry Software Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 14. By Region - Global Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 15. By Country - North America Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 16. US Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 20. Germany Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 21. France Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 28. China Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 32. India Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 34. Brazil Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Standalone Cancer Registry Software Revenue Market Share, 2018-2029
Figure 37. Turkey Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Standalone Cancer Registry Software Revenue, (US$, Mn), 2018-2029
Figure 41. McKesson Corporation Standalone Cancer Registry Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Elekta Standalone Cancer Registry Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. C/NET Solutions Standalone Cancer Registry Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Electronic Registry Systems Standalone Cancer Registry Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Rocky Mountain Cancer Data Systems Standalone Cancer Registry Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Onco Standalone Cancer Registry Software Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
